Type2Diabetes
100
29
37
39
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 100 trials
100.0%
+13.5% vs benchmark
11%
11 trials in Phase 3/4
10%
4 of 39 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 39 completed trials
Clinical Trials (100)
TRE in Type 2 Diabetes (See Food Study 3)
NAD Augmentation in Diabetes Kidney Disease
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
The CARING Study: Creating and Restoring Health Through Nutrition Guidance
Finerenone and Renal Oxidative Stress
AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy
The Bennett Kids PowerUP Project
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
Integrating a Prescription Produce Program Within a Diabetes Prevention Program
Type 2 Diabetes and Blood Brain Barrier Improvement
The Effects of Glucagon on Hepatic Metabolism
Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity
Mitochondrial Substrate Utilization in the Diabetic Human Heart
Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment
Comorbidities Resolution After MGB Surgery and Change in Body Composition
Ketones, SGLT2, HFrEF
Telehealth Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes
The PIVOT Trial: Project on EHR-Integrated Lifestyle Interventions for Adults Aged Fifty and Older
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans
Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants